AbbVie

MA strategy deal block push come together form
Biotech

M&A remains ‘top priority’ for pharmas in face of tariff threat

Big Pharmas aren’t letting the looming threat of potential tariffs divert them from their M&A strategies for the year—at least for the time being.
James Waldron Apr 25, 2025 10:41am
Heidelberg Germany

German program matches lost NIH grants with pharma funders

Apr 7, 2025 10:50am
The Top Line

A closer look at pharma's top R&D budgets

Apr 4, 2025 9:34am
A representation of golden gas or oil pipes surrounded with coins on financial graph with candle bars

Top 10 pharma R&D budgets in 2024

Mar 31, 2025 6:00am
Manila folder with CONFIDENTIAL printed on it in red

AbbVie alleges Genmab 'willfully blind' to trade secret theft

Mar 24, 2025 5:51am
finance numbers tape money

AbbVie pays Gubra $350M to make late play for obesity space

Mar 3, 2025 4:48am